Affinity Asset Advisors’s Vir Biotechnology VIR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-200,000	Closed	-$1.78M	–	100
2024 Q2	$1.78M	Buy	+200,000	New	+$1.78M	0.21%	62
2023 Q3	–	Sell	-20,000	Closed	-$491K	–	81
2023 Q2	$491K	Buy	+20,000	New	+$491K	0.17%	57